This inventor holds 3 USPTO granted patents. Top assignees: Eisai R&d Management Co., Ltd., Epizyme, Inc.. Active years: 2012-2018.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
3 out of 530 
2 out of 159 
Years Active: 2012-2018
Title: Frances Fang – Innovator in Histone Methyltransferase Inhibitors
Introduction
Frances Fang is a distinguished inventor based in Andover, MA, recognized for her contributions to the field of biochemistry, particularly in the development of histone methyltransferase inhibitors. With three patents to her name, she focuses on innovative solutions that have the potential to significantly impact therapeutic approaches in cancer treatment.
Latest Patents
Frances has made notable advancements with her latest patents, which include the invention of a salt form of a human histone methyltransferase EZH2 inhibitor. The primary compound described in her patents is N-((4,6-dimethyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-5-(ethyl(tetrahydro-2H-pyran-4-yl)amino)-4-methyl-4'-(morpholinomethyl)-[1,1′-biphenyl]-3-carboxamide hydrobromide. Additionally, her patents detail a particular polymorph form of this compound, showcasing her innovative approach to drug development.
Career Highlights
Throughout her career, Frances has collaborated with leading organizations in the pharmaceutical industry, including Eisai R&D Management Co., Ltd and Epizyme, Inc. Her work has significantly influenced research practices and has contributed to the advancement of methyltransferase inhibitors utilized in clinical settings.
Collaborations
Frances has had the opportunity to work alongside talented individuals such as Kevin Wayne Kuntz and Kuan-Chun Huang. These collaborations have enriched her research, allowing for the exchange of ideas and the pursuit of innovative solutions in the realm of biochemistry and drug development.
Conclusion
Frances Fang stands out as an exemplary inventor who is dedicated to advancing the field of histone methyltransferase inhibitors. Her innovative patents and professional collaborations highlight her commitment to improving therapeutic options for patients. As she continues her work, she undoubtedly inspires others in the scientific community to pursue their creative ideas and contribute to impactful innovations.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile